- FY27 adjusted EPS guidance: $12.00-$12.25 per share
- ResMed reaffirms FY27 adjusted EPS guidance $12-$12.25.
ResMed backed its FY27 adjusted EPS guidance of $12.00-$12.25 per share, following a Q1 earnings beat that included revenue and EPS above consensus.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.